As a first step investigating the relationship between fIGF-1 in plasma and tumour EMT, E-cadherin and vimentin levels were quantified using F-IHC in tumour biopsies of 45 patients enrolled in Study 1002. The gene discussed is CDH1; the disease is neoplasm.